🇺🇸United States·March 17, 2026·daily

S&P 500 Consumer Discretionary Sector SEC Filings — March 17, 2026

Across 50 filings in the S&P 500 Consumer Discretionary stream (with cross-sector context from retail, hotels, airlines, and adjacent), key themes include robust revenue growth in 8/14 reporting companies (avg +45% YoY, led by Dragonfly +15.8%, Fold +34%, Marwynn +122%) offset by widespread margin compression (avg -200bps) and widening losses (e.g., Fold op loss to $27.7M, SafeSpace -41% YoY), signaling cost pressures amid RV/auto softness and ops disruptions. Capital allocation remains shareholder-friendly with new buybacks ($250M First Industrial, Kforce 10b5-1 plan, CF $1.37B repurchases), steady dividends (Waterstone quarterly, First Guaranty 131st consecutive), and M&A activity ($800M+ Infinity upstream, Fulgent $56.9M assets, Farmer Bros merger). Proxy season ramps up with 15+ AGMs in April-May 2026, highlighting board refreshers and comp votes. Forward guidance mixed: Dragonfly targets EBITDA positivity at $70M run-rate, Frontier Q1 loss $0.32-0.44 amid fuel spikes. Portfolio-level: 6/10 high-materiality filings show mixed sentiment, with hotels/entertainment stable but airlines volatile; actionable now on buybacks amid undervalued growth names.

26 high priority24 medium50 total filings

🇺🇸United States·March 17, 2026·daily

S&P 500 Healthcare Sector SEC Filings — March 17, 2026

Across 41 diverse SEC filings labeled under USA S&P 500 Healthcare (though spanning retail, biosciences, energy, finance, and more), overarching themes include modest revenue growth averaging ~12% YoY in 8/41 reporting companies (e.g., Lifeway +14%, PURE Bioscience +22%, Zeo +33%), offset by persistent net losses in biosciences and cash burn concerns; margin expansions noted in standouts like Citi Trends (+210bps FY to 39.6%) and Lifeway (+140bps to 27.4%). Healthcare-adjacent biosciences (7 filings) show revenue up avg 15% YoY but mixed sentiment with narrowing losses (PURE -16%, Cibus -53%) amid clinical catalysts and M&A (Rallybio merger). Capital allocation leans toward buybacks (News Corp $1B program, New Peoples 500k shares) and dividends (Waterstone quarterly), while energy names like New Fortress face severe restructuring (debt cut to $527.5M, shareholder dilution to 35%). Critical developments: bioscience efficiency gains and product launches (Cibus rice traits 2027-28), SPAC mergers for growth (Abra $10B AUM target 2027), but restatements/restatements signal control weaknesses. Portfolio implications: selective opportunities in high-growth biosciences/turaround retail, caution on cash-strapped microcaps and leveraged restructurings.

19 high priority22 medium41 total filings

🇺🇸United States·March 16, 2026·daily

S&P 500 Consumer Staples Sector SEC Filings — March 16, 2026

Across 50 filings in the USA S&P 500 Consumer Staples intelligence stream (with broader cross-sector context), dominant themes include steady capital returns via dividends (Benchmark $0.17/shr, Pebblebrook $0.01 common + prefs, Coca-Cola resilient outlook), frequent leadership transitions signaling strategic shifts (KORU CEO retirement 6/30/26, Helmerich CFO 6/30/26, Coca-Cola CEO to Henrique Braun), and mixed financials with revenue acceleration in 8/18 reporting companies averaging +32% YoY (Telos +52%, Gilat +48%, OPAL +16%) offset by margin compression in 7/12 cases averaging -380bps (Gilat -700bps, Dell products -210bps). Period-over-period trends reveal improving cash flows in turnarounds (Telos op CF +$56.1M to $30.2M, Comtech H1 +$34.9M to $12.9M) but widening losses in 6/15 small caps (KEEMO -62% worse, FutureFuel rev -61%). Forward-looking catalysts cluster in Q2-Q3 2026 (DuPont aramids sale 4/1, Black Diamond GBM trial Q2, Rafael topline Q3), with OPAL's 2026 EBITDA guidance $95-110M as a growth beacon. Portfolio implications favor selective longs in high-growth outliers like OPAL/Telos amid sector volatility, with watch for M&A closes and trial readouts driving alpha.

28 high priority22 medium50 total filings

🇺🇸United States·March 16, 2026·daily

S&P 500 Industrials Sector SEC Filings — March 16, 2026

Across 50 filings in the USA S&P 500 Industrials stream, key themes include robust revenue acceleration in power/infrastructure plays like Forgent Power Solutions (+69% YoY to $296M Q2, bookings +268%) and WaterBridge (+66% YoY to $525.6M FY25), offset by volume pressures in defense (SAIC -5% YoY Q4) and machinery (Comtech -16% YoY Q2 sales). Aggregate period trends: 8/15 revenue-reporting firms showed +20%+ YoY growth (avg +55%), but 6/10 reported net losses or widened due to one-offs, impairments, and debt costs; margins resilient in 4 cases (Comtech +720bps, SAIC +20bps FY). Capital allocation bullish with $422M SAIC buybacks, Amphastar +$50M program, multiple dividend hikes/initiations (ServisFirst $0.38, WaterBridge $0.05). M&A active: Public Storage-NSA merger (multiple filings), Addentax Keemo acquisition. Banks exhibit NI surges (+45% PCB, +49% Orange County) but rising NPAs/NPLs (+69% PCB nonaccruals, +76% Orange NPLs). Forward-looking signals mixed: Forgent +73% FY26 guide vs SAIC -4-2% organic; catalysts cluster Mar-Apr AGMs/earnings and Q2 2026 BLAs. Actionable: overweight infra growth, monitor credit deterioration.

25 high priority25 medium50 total filings

🇺🇸United States·March 16, 2026·daily

S&P 500 Energy Sector SEC Filings — March 16, 2026

Across the 8 S&P 500 Energy stream filings (with some industrial/biotech outliers), key themes include robust revenue growth in 5/8 companies (e.g., Ampco-Pittsburgh +4% YoY FY sales to $434.2M, Stoke +404% YoY to $184M) offset by one-time losses and margin pressures, exemplified by Ampco's Q4 Adjusted EBITDA -47% YoY to $3.2M and FY operating loss of $(54.5M). Energy pure-plays shine: Marathon Petroleum (MPC) reported $4.0B 2025 net income, $12.0B adjusted EBITDA, 94% refining utilization, and $4.5B shareholder returns including 10% dividend hike to $1.00/share, while Dorchester Minerals secured $15.5M litigation settlement boosting April 2026 distributions. Capital allocation leans shareholder-friendly in energy (MPC $4.4B buyback authorization remaining), with forward-looking uplift from Ampco's UK facility exit ($7-8M annual EBITDA). Proxies signal routine governance (MPC DEFA14A/DEF14A, Peapack), but mixed sentiment prevails in 3/8 filings due to charges/backlog declines. Portfolio implications: Favor MPC/Dorchester for near-term yields; monitor Ampco/Stoke turnarounds amid Q4 weakness. Catalyst-rich: Earnings calls and AGMs in March-April 2026.

5 high priority3 medium8 total filings

🇺🇸United States·March 16, 2026·daily

S&P 500 Financials Sector SEC Filings — March 16, 2026

Across 50 filings from S&P 500 Financials and related streams, overarching themes include mixed financial performance with revenue declines averaging -7% YoY in 14/25 reporting companies (e.g., Townsquare -5.2%, iQIYI -6.6%, LivePerson -22%) offset by aggressive cost reductions boosting operating income (e.g., Townsquare +103.8%) and EBITDA (WaterBridge +68% to $254M); notable M&A and capital markets activity like Kennedy-Wilson merger amendments requiring 2/3 vote excl. insiders, Armada Hoffler $562M asset sale, and MSC Income $150M notes. Fintech standouts like Figure Technology (+48.7% rev to $507M, +574% NI) and Blend Labs (+7% rev, op cash flow positive $14.4M) contrast with bank/insurer stability (PCB Bancorp +45% NI, AIG director exit neutral). Capital allocation favors buybacks (Amphastar +$50M) and dividends (Townsquare $0.20 qtrly, PCB +11%), while SPACs extend deadlines amid redemptions (Trailblazer to June 2026). Forward guidance mixed but growth-oriented (Townsquare FY2026 $420-440M rev, WaterBridge +7-9% EBITDA), signaling portfolio-level resilience amid sector rotation opportunities. Implications: Favor fintech/bank growth outliers, monitor merger votes and Q1 catalysts for alpha.

32 high priority18 medium50 total filings

🇺🇸United States·March 16, 2026·daily

S&P 500 Technology Sector SEC Filings — March 16, 2026

Across 14 SEC filings in the USA S&P 500 Technology stream, revenue declines dominate with 4 key reporters averaging -10.7% YoY (Townsquare -5.2%, Comtech Q2 -15.6%/H1 -10.2%), driven by broadcast/advertising weakness and product eliminations, but countered by margin expansions via cost cuts (Comtech gross margin +720bps to 33.9%, Adjusted EBITDA +214% to $9.1M; Townsquare op income +103.8%). Capital allocation trends bullish in software giants: Intuit accelerated buybacks +40% YoY to $1.8B H1 with $3.5B remaining after terminating 10b5-1 sales plans; Salesforce $25B ASR signals conviction. Digital shifts resilient (Townsquare digital +0.9% to 55% of rev), turnarounds evident (Nuvera NI +107.4% to $0.3M from $4.4M loss), but debt pressures persist (Townsquare leverage 5.19x, interest +32.3%). Mixed sentiment in 5/14 filings reflects operational resilience amid macro headwinds; backlog strength (Comtech $732M, +120.9% bookings) flags recovery potential. Guidance cautious (Townsquare FY26 rev $420-440M flat YoY), with catalysts like AParadise De-SPAC and May events. Portfolio implication: overweight buyback leaders (Intuit, Salesforce), monitor small-cap debt for downside.

8 high priority6 medium14 total filings

🇺🇸United States·March 16, 2026·daily

Nasdaq 100 Stocks SEC Filings — March 16, 2026

Across the 13 NASDAQ-100 related filings from March 16, 2026, key themes include margin expansion and profitability improvements despite revenue softness in select companies like Comtech (Q2 sales -15.6% YoY but gross margin +720 bps to 33.9%, Adjusted EBITDA +214% to $9.1M), contrasting with positive capital allocation signals such as Intuit's termination of 10b5-1 sales plans and acceleration of $3.5B share repurchases (H1 repurchases +40% YoY to $1.8B). Amazon's €14.5B Euro notes issuance at low coupons (2.8%-4.85%) signals strong access to cheap debt markets, while SPAC/IPO activity (Metals Acquisition $200M IPO, Madison Air S-1/A) highlights M&A momentum. Governance enhancements (CoStar's new AI-experienced director) and operational outperformance (AParadise's AOV +18%, subscription +25%) point to AI/data tailwinds, but debt pressures persist (Nuvera interest expense up, Comtech non-current debt +$7.9M to $103.5M). Portfolio-level trends show 3/5 detailed financial reporters with YoY profitability gains (e.g., Comtech H1 gross profit +51.3%, Nuvera net income +107.4% from loss), mixed revenue (2 declines averaging -13%), and bullish capital returns. Critical implications: Favor margin turnarounds and buyback accelerators amid soft revenue; monitor De-SPACs and reporting changes for catalysts.

8 high priority5 medium13 total filings

🇺🇸United States·March 16, 2026·daily

Dow Jones 30 Stocks SEC Filings — March 16, 2026

Across 50 SEC filings from Dow Jones 30-focused stream (Mar 16, 2026), key themes include resilient banking sector growth with net income up 45-49% YoY in PCB Bancorp/Orange County Bancorp amid NIM expansion, contrasted by revenue declines averaging -15% YoY in tech/defense firms like SAIC (-3% FY26), LivePerson (-22%), and Comtech (-15.6% Q2 FY26), though margins improved (e.g., Comtech gross margin +720bps to 33.9%). M&A activity surged with 6 deals (Interactive Strength/Ergatta $3.5M+$5-9.5M stock, Allison/Dana $2.73B, Zevra SDX sale $50M), leadership transitions in 10+ firms (Fortune Brands interim CEO, Baxter interim CFO), and capital returns via dividends/buybacks (SAIC $422M FY26 repurchases, ServisFirst $0.38/share). Mixed sentiment dominates (18/50), with forward guidance cautious (SAIC FY27 rev -4-2% organic) but clinical catalysts (Perspective VMT-α-NET mid-2026 data) and bank efficiency gains (PCB ROA 1.15% +). Portfolio implications: overweight banks for NIM tailwinds, monitor tech margin recovery vs rev weakness, position for M&A catalysts.

27 high priority23 medium50 total filings

🇺🇸United States·March 16, 2026·daily

S&P 500 Consumer Discretionary Sector SEC Filings — March 16, 2026

Across the 50 filings in the USA S&P 500 Consumer Discretionary intelligence stream (despite diverse inclusions like infra/energy/crypto), mixed sentiment dominates with 18/50 showing mixed signals, driven by robust revenue growth in select names (e.g., Forgent Power +69% YoY Q2 rev to $296M, Figure Tech +48.7% FY25 to $507M) offset by declines (SFL Corp -19% rev to $733M, FutureFuel -61% to $95.7M). Period-over-period trends reveal YoY revenue acceleration in 15/50 companies averaging +40% where positive, but margin compression in 12/50 (avg -100bps) and net losses widening in 10/50 due to impairments/expenses. Capital allocation shines with dividends declared/initiated in 5 names (ServisFirst $0.38/shr, WaterBridge $0.05/shr quarterly) and buybacks noted (Truist $10B program, Marathon $4.5B returned). M&A momentum includes NSA/Public Storage merger (3 filings), Armada Hoffler $562M asset sale, and KEEMO control stake acquisition. Forward-looking guidance is bullish in infra/power (Forgent FY26 rev $1.275-1.325B +73%), with April 2026 AGMs (Ferguson, Truist, Marathon) as key catalysts. Crypto ETF index changes (Grayscale BTC/ETH, 5 filings) are neutral operational tweaks effective Apr 1. Portfolio implication: favor growth infra/consumer plays amid capex cycles, monitor M&A for consolidation.

28 high priority22 medium50 total filings

🇺🇸United States·March 16, 2026·daily

S&P 500 Healthcare Sector SEC Filings — March 16, 2026

In the USA S&P 500 Healthcare stream, biotech and medtech firms dominate with mixed but stabilizing financials: revenues grew in devices (Smith & Nephew +6.1% YoY) while core sales declined in nutritionals (USANA -8.3% YoY), and biotechs narrowed losses (Rallybio -84% net loss YoY, HeartSciences -4% 9mo) amid pipeline catalysts. Cash positions strengthened significantly (Alto +5% to $177M funding into 2028, HeartSciences +209% to $3.4M), supported by $120M Alto raise and operational efficiencies (Rallybio opex -44% YoY). Broader filings reveal robust capital returns (SAIC $422M FY26 buybacks, Truist $10B new program, $5.2B returned 2025) and proxy season peaks with 10+ April 2026 meetings. Forward-looking optimism in healthcare via Alto's 1Q26/1H26 data/trials, Moderna's 8 oncology programs, Smith & Nephew's 6-7% CAGR RISE plan to 2028. Portfolio trends: 5/8 key HC firms improved cash/equity YoY, but margins compressed avg -150bps in 3/8 (USANA -370bps op); non-HC financials showed net income growth avg +25% YoY (SMARTFinancial +39%). Critical implications: Biotech catalysts cluster 1H26, signaling alpha in small/mid caps; monitor dilution from raises and weak bookings (SAIC Q4 btb 0.3x).

30 high priority20 medium50 total filings

🇺🇸United States·March 13, 2026·daily

S&P 500 Consumer Staples Sector SEC Filings — March 13, 2026

Across 50 recent SEC filings from the USA S&P 500 Consumer Staples intelligence stream (with broader equity coverage), overarching themes include sustained capital returns via dividends and buybacks amid mixed FY2025/Q4 results, neutral-to-positive insider activity focused on planned diversification rather than opportunistic selling, and cautious forward-looking guidance with strategic reviews in non-core assets. Period-over-period trends reveal revenue growth in 7/15 detailed reporters (avg +12% YoY, e.g., monday.com +27%, CCEP +FX-neutral), but margin compression in 6/15 (avg -100bps, e.g., Velocity NIM -11bps, Aspen gross margin -2300bps), offset by efficiency gains (e.g., Fidelity D&D efficiency ratio -590bps to 60.3%). Critical developments feature CCEP's strong €20.9B revenue and €1B buyback completion signaling staples resilience, Walmart executives' 10b5-1 plans for routine sells up to $15M through 2029 (neutral conviction), and Petco/El Pollo Loco's modest sales growth (+3.6%/-2.5%) with profitability improvements. Portfolio-level patterns show 9/50 filings with dividends/buybacks (e.g., GIII $0.10, Ford 31.7M shares), indicating robust shareholder focus despite sector headwinds like flat same-store sales (El Pollo 0.1%). M&A/strategic processes (e.g., Barnwell oil/gas review, Monroe approvals) add alpha potential, while layoffs (Modular 29% workforce) flag cost pressures. Implications favor defensive staples plays with yields, monitoring catalysts like March 18 hearings and Q1 earnings.

26 high priority24 medium50 total filings

🇺🇸United States·March 13, 2026·daily

S&P 500 Industrials Sector SEC Filings — March 13, 2026

Across 50 SEC filings for the USA S&P 500 Industrials intelligence stream (though spanning financials, energy, healthcare), bank 10-Ks dominate with resilient growth: ~12 banks averaged 4.5% YoY asset growth, 12% YoY NII increase, and 20bps NIM expansion (e.g., Red River +25% net income, Princeton +82%), offset by rising NPAs/provisions in 4 cases (avg +200%). Industrials shine with Venture Global's landmark $20.7B CP2 LNG financing (Phase 2 FID $8.6B, no equity needed, targeting 100+ MTPA capacity), Ducommun's record $824.7M revenue (+49% stock gain under VISION 2027), and ArcBest's $4B revenue/$86M returns despite freight weakness. Capital allocation trends positive: 5 dividends (GIII $0.10, Designer $0.05), buybacks (First Northern 1M shares thru Apr'26), stock div (First Northern 5% payable 3/25). Forward-looking catalysts include Better Home's Q1'26 loan vol guide $1.4-1.55B (post +56% YoY Q4), Tonix cash runway to Q1'27, and proxy meetings clustered Apr-May'26. Mixed sentiment (60% mixed/neutral) signals stability but credit watch; overweight NII-expanders like Fidelity D&D (+16.7% NII), avoid NPA outliers like Isabella (+553%). Portfolio implication: Industrials/financial hybrids offer defensive alpha via returns/M&A amid macro caution.

34 high priority16 medium50 total filings

🇺🇸United States·March 13, 2026·daily

S&P 500 Energy Sector SEC Filings — March 13, 2026

Across these 7 diverse SEC filings (primarily real estate, banking, pharma/consumer health despite energy stream context), overarching themes include mixed financial performance with modest revenue growth offset by widening losses, impairments, and operational pressures in real estate entities. Period-over-period trends reveal revenue increases (BRT +1.5% YoY to $97M, Copper lease income +2% YoY to $96M, John Marshall NII +18.6% YoY) but declining profitability (BRT FY net loss to $(11.9M) from $(9.8M), Copper net income -36% YoY to $47M, same-store NOI flat/declining across BRT/Copper). Real estate-focused filings (BRT x2, Copper, Kaanapali) dominate with portfolio expansions/sales, higher debt costs, and impairments, while banking (John Marshall) shows robust +24% YoY net income growth to $21.2M and Haleon delivers clean audits. Capital allocation leans toward share repurchases (BRT 321k shares) and dividends (maintained $0.25 Q at BRT, $0.30 at John Marshall), but no insider trading patterns noted. Critical developments like Bioxytran's impairments/leadership changes signal distress, while land sales (Kaanapali +$10.3M gain) and bank asset growth (+4.4% to $2.33B) offer pockets of strength. Market implications: Heightened caution on real estate amid NOI declines and debt maturities, selective opportunities in growing financials; portfolio-level trend of margin compression (e.g., Copper NOI -7%, BRT AFFO flat) suggests broader sector vulnerability.

6 high priority1 medium7 total filings

🇺🇸United States·March 13, 2026·daily

S&P 500 Financials Sector SEC Filings — March 13, 2026

Across 50 SEC filings purportedly from S&P 500 Financials (though spanning diverse sectors including pharma, hospitality, REITs, and banks), overarching themes include mixed sentiment with revenue growth in 12/20 reporting companies averaging +16% YoY (e.g., ONE Group +19.7%, Emerald +16.2%, Jefferson Capital +41.6%) offset by Q4 weakness, widening net losses (9/20 cases), and expense surges (e.g., Tonix SG&A +119%). True financials like Red River Bancshares (+25% net income, NIM +14bps to 3.38%), First Northern (+4.8% NII, NIM +17bps), Republic Bancorp (NPS +12% to 73.4), and Jefferson Capital (+45.8% net income) show resilience amid deposit declines elsewhere. Capital allocation leans shareholder-friendly with buybacks (News Corp $1B program, Emerald $17.5M repurchased, First Northern 1M+ shares authorized) and dividends (Emerald doubled to $0.06/share, BRT $0.25 Q). Insider activity limited to routine Walmart 10b5-1 plans (e.g., McMillon 155k shares). Forward-looking guidance optimistic for 2026 (ONE Group +4-6% rev, Emerald +6-7%), but risks from auditor changes (Amplify material weakness), lawsuits (Scilex fraud claims), and M&A approvals (Signing Day closes March 16). Portfolio-level: margin expansion in banks (3/4 improved), but REITs/others flat NOI; actionable now on catalysts like March 16-18 events.

30 high priority20 medium50 total filings

🇺🇸United States·March 13, 2026·daily

S&P 500 Technology Sector SEC Filings — March 13, 2026

Across 20 SEC filings from the USA S&P 500 Technology stream (including adjacent financials/tech enablers), overarching themes include mixed financial performance in community banks with net interest margin (NIM) expansions averaging +20 bps YoY in 3/5 reporters offsetting non-interest income declines (e.g., Chemung -65.8%), aggressive capital returns via buybacks and dividends, positive proxy outcomes with strong approvals, and strategic M&A/debt issuances signaling growth confidence. Period-over-period trends show NII growth averaging +8% YoY (First Northern +4.8%, Chemung +17.7%, NorthEast -2%), but net income declines in 4/8 reporters (Chemung -36.2%, NorthEast -5.65%); tech highlights feature Salesforce's $25B debt-for-buybacks and Intuitive Surgical's leadership transition. Critical developments: Esquire-Signature $350M accretive merger (20-25% 2027 EPS acc.), Aditxt's $36M oncology acquisition, and MultiSensor AI's $60M ATM for growth capital. Portfolio-level patterns reveal shareholder-friendly capital allocation (buybacks in 3 firms, stock dividend), proxy successes (5/5 positive), but deposit declines (First Northern -7.3%) and revenue softness (RideNow -10.5% YoY) flag liquidity pressures. Tech sector shows conviction via debt-funded returns and M&A into AI/oncology, positioning for catalysts like Q3 2026 deal closes.

16 high priority4 medium20 total filings

🇺🇸United States·March 13, 2026·daily

Nasdaq 100 Stocks SEC Filings — March 13, 2026

Across 19 filings from NASDAQ-100 related entities, community banks dominate with mixed 2025 results: net income declined YoY in all three (First Northern flat assets, Chemung -36.2% to $15.1M due to $17.5M securities loss offset by NII +17.7%, NorthEast -5.65% to $44.4M with NIM contracting -37bps), though NIM expanded in two (+17bps First Northern, +50bps Chemung) amid deposit declines (-7.3% First Northern). Positive corporate governance shines with overwhelming AGM approvals (Adient, Applied Materials, Ducommun record $824.7M rev +49% stock gain), leadership transitions (Intuitive Surgical CEO change), and capital raises (Amazon $37B notes for $36.8B net proceeds, NexMetals cash +551% to $39.8M post $80M financing). Biotech M&A/licensing active (Aditxt $36M Ignite acquisition targeting $3B market, AC Immune Takeda deal up to $2.1B milestones). Capital allocation favors shareholders via repurchases (First Northern 1M+ shares thru Apr 2026), stock div (5% First Northern), retention RSUs/awards (Adient $500K, Optimum $9.4M DCAs). Portfolio trend: financials show resilient NII growth (avg +8.8% YoY) despite one-offs, tech/industrials bullish on strategy execution. Key implication: Favor banks with NIM expansion and buybacks; monitor biotech catalysts amid loss risks.

13 high priority6 medium19 total filings

🇺🇸United States·March 13, 2026·daily

Dow Jones 30 Stocks SEC Filings — March 13, 2026

Across 50 SEC filings from March 13, 2026, primarily regional banks and select energy/financial firms (despite DJ30 stream focus, data spans broader US blue-chips and mid-caps), FY2025 10-Ks reveal mixed resilience: 9/15 banks reported asset growth averaging 6-62% YoY (e.g., ChoiceOne +62%), NIM expansions in 7/15 (avg +20bps, e.g., Red River +14% to 3.38%), but provisions spiked sharply in outliers (ChoiceOne +2,367% to $14.8M). Energy sector shines with accretive M&A (Battalion Oil adds 30 drilling locations) and mega-financings (Venture Global $20.7B CP2 LNG FID). Capital allocation tilts shareholder-friendly (buybacks/dividends in CCEP €1B, First Northern 1M+ shares, Universal $0.105/share), amid neutral insider plans (Walmart exec 10b5-1 sales for diversification). Forward catalysts cluster in April-May AGMs (10+ meetings) and deadlines (Olenox registration Apr 11); sentiments mixed/neutral dominate (28/50), with positive outliers in growth stories. Portfolio implication: overweight regional banks with NIM tailwinds/strong ROE (Red River 12.58%), monitor provision risks; energy M&A offers alpha amid LNG demand.

38 high priority12 medium50 total filings

🇺🇸United States·March 13, 2026·daily

S&P 500 Consumer Discretionary Sector SEC Filings — March 13, 2026

Across 50 filings in the S&P 500 Consumer Discretionary stream (heavily skewed toward financials, retail/auto/entertainment), FY2025 results show mixed trends with robust revenue/NII growth averaging +30-50% YoY in outperformers like Jefferson Capital (+41.6%), Velocity Financial (+69% Q4 net income), and Better Home & Finance (+52% revenues), but widespread profitability erosion via compressed ROA/ROE (e.g., CHOICEONE ROA -31bps to 0.69%), exploding provisions (CHOICEONE +2367% to $14.8M), and rising expenses. Capital allocation leans bullish with buybacks (Ford 31.7M shares, CCEP €1B completed, Amazon/Salesforce debt-funded repurchases), stock dividends (First Northern 5%), and M&A (IF Bancorp merger delisting, Burke & Herbert board changes). Consumer discretionary standouts include Ford's anti-dilutive buyback, Walmart insider diversification plans (neutral), and Amazon's $37B notes for buybacks; entertainment sees director exits (Six Flags). Forward catalysts cluster in Q1-Q2 2026 (Better Home $1.4-1.55B Q1 volume, breakeven Q3), with risks from auditor changes (Amplify, Black Rock Coffee material weaknesses) and liquidity strains (Maris Tech substantial doubt). Portfolio implication: Favor growth financials with NIM expansion (First Northern +17bps, Fidelity D&D +16.7% NII) over deteriorating ones; monitor consumer buybacks for conviction.

36 high priority14 medium50 total filings

🇺🇸United States·March 13, 2026·daily

S&P 500 Healthcare Sector SEC Filings — March 13, 2026

Across 48 SEC filings from the USA S&P 500 Healthcare stream (with heavy financial sector overlap), overarching themes include mixed financial performance in regional banks with net interest margin (NIM) expansions averaging +50bps YoY in 5/9 reporting banks (e.g., ChoiceOne +66bps to 3.61%, Norwood +58bps to 3.49%) offset by ROE declines in 4/7 (avg -300bps) due to higher provisions and expenses; healthcare firms show leadership transitions signaling continuity (Cigna CEO change July 2026, Intuitive Surgical CEO April 2026). Period-over-period trends reveal revenue growth in 6/15 detailed firms (avg +25% YoY, e.g., Norwood NII +26%) but net income volatility (wins like Franklin +91%, losses like Harvard Bioscience -$56.7M due to $48M goodwill impairment). Capital allocation leans shareholder-friendly with buybacks (CCEP €1B completed, News Corp $1B ongoing, Franklin 6,500 shares repurchased) and dividends (NewtekOne $0.19/share Q2 2026, SAIC $0.37/share). Healthcare-specific signals include positive proxy sentiments for Abbott and Intuitive Surgical, while Scilex's lawsuit adds sector litigation risk. Portfolio-level: 12/48 mixed sentiment filings highlight integration/M&A pressures (Esquire-Signature $350M deal 20-25% accretive), with upcoming AGMs (April 2026 cluster) as catalysts. Implications: Favor NIM expanders with strong capital returns; monitor healthcare leadership for execution risks.

31 high priority17 medium48 total filings